Introduction This study aimed to investigate if maternal pregnancy exposure to metformin is
associated with increased risk of long-term and short-term adverse outcomes in the child …

Background and purpose Studies have not yet found conclusive results on the risk of cancer
in patients with multiple sclerosis (MS). This study aimed to compare the incidence of all …

Introduction As the ear development extends from the 4th to the 30th week of pregnancy, in
utero exposure to ototoxic drugs might lead to hearing impairment in the fetus. The main …

Aim This study assessed whether cetuximab 500 mg/m 2 administered every 2 weeks
(Q2W), when combined with chemotherapy as a first-line (1L) treatment, was noninferior to …

This study estimated the incidence of malignancy in patients with multiple sclerosis (MS)
versus a matched general population cohort in the Netherlands. Adults with a diagnosis of …

Introduction We previously reported an increased risk of being small for gestational age
(SGA) and a decreased risk of being large for gestational age (LGA) after in utero exposure …

Background The association between multiple sclerosis and malignancy is controversial
and a current appraisal is needed. Objective To determine the incidence of malignancy in …

Aim. The aim of the study was to compare the effectiveness of beta-blockers with other
antihypertensive classes in reducing all-cause mortality, cardiovascular-related mortality …

Aim: To compare blood pressure (BP) and safety outcomes in patients with hypertension
initiating bisoprolol, versus other β-blockers, angiotensin-converting enzyme …

Purpose The objective was to compare the risk of malignancies in real‐world settings
between exclusive immunosuppressant (IS) and immunomodulator (IM) use in multiple …